The Role of Advanced Molecular Diagnostics in Pathogen Detection
Explore how molecular diagnostics transform pathogen detection, providing faster, more accurate results compared to traditional testing methods
Testing Trends-dtet
How Advances in T-Cell Receptor Profiling Can Boost Early Cancer Diagnosis
New developments in flow cytometry and molecular biology promise to improve the detection of rare cancers
Diagnostics Pipeline: Savara Introduces Blood Test to Detect aPAP, a Rare Lung Disorder
Savara’s ClearPath assay needs just a few drops of blood to test for aPAP, a condition that can be difficult and invasive to diagnose
Criteria-Based Ordering Improves Vitamin D Testing
...
Already a member? Log in here
Evidence Emerging for More Use Cases for High-Sensitivity Troponin
...
Already a member? Log in here
USPSTF Updates Colorectal Cancer Screening Guidelines to Include Molecular Test
From - Diagnostic Testing & Emerging Technologies
The U.S. Preventive Services Task Force (USPSTF) added molecular colorectal cancer (CRC) screening to its newly updated guidelines, but stopped short of…
Large Panels Complicate Results Reporting for Breast Cancer Risk
...
Already a member? Log in here
Orgs Plan for Personalized Medicine Growth over Next Few Years
From - Diagnostic Testing & Emerging Technologies
Health care experts predict growth and maturation happening in the field of personalized medicine in the next two…
Prospective Trial Shows Utility of Liquid Biopsy for Lung Cancer
...
Already a member? Log in here
Molecular Profiling of Lung Cancer Tumors Feasible on National Scale
From - Diagnostic Testing & Emerging Technologies
Routine, nationwide molecular profiling of patients with advanced non-small cell lung cancer (NSCLC) is feasible and the screening detects actionable alterations that…
Viewpoints Debate Merits of Universal Tumor Sequencing
From - Diagnostic Testing & Emerging Technologies
There is universal recognition that genomic information has forever changed oncology care and is increasingly driving treatment decisions. For patients who have exhausted standard therapy or with…
